Introduction
Although early reports of rounded atelectasis (RA) date back to 1928, it remained poorly understood for a long period of time. 1 Hanke and Kretzschmar refined its radiologic features, and proposed the term ''atelectatic pseudotumor of the lung'' in 1980. 2 The synonyms for RA that have been used since it reflects the confusion on its pathogenesis: Blesovsky's syndrome; pleuroma; folded lung atelectasis; shrinking pleuritis with atelectasis; helical atelectasis; spherical and cylindrical atelectasis. [3] [4] [5] RA is the least common of all benign asbestos-induced pleural and parenchymal lung changes. 6 It represents an unusual form of peripheral lung collapse accompanying pleural effusions. The mean age of RA patients in one study was 65713 years; among them an 83% of active or ex-smokers. 7 This entity has also been reported in non-smokers, 8 and is a rare cause of solitary pulmonary nodule (SPN) in immunocompetent and immunocompromised patients. 9 Besides history and physical examination, plain chest radiography used to be the only diagnostic tool unraveling RA; the advent of computed tomography (CT) contributed to a more accurate discrimination of the lesion. 10 Asbestos exposure is still the leading etiologic factor for the development of RA. Nevertheless, more infrequent causes are not to be overlooked. Two main theories have emerged addressing RA's pathogenesis: the ''folding (pleural effusion)'' and the ''fibrosing (pleural injury)'' concepts. 11, 12 In this article, we summarize pertinent clinical and radiological aspects of RA, discuss its pathogenesis and relationship to lung cancer, and attempt to provide useful guidance to the physician managing a case of RA.
Etiology
RA was originally observed in patients treated with collapsotherapy (i.e. induction of iatrogenic pneumothorax for the treatment of cavitary pulmonary tuberculosis). A striking predilection of RA for patients with a history of pleurisy was noted shortly thereafter. In the early 1980s, coinciding with the discrimination of asbestos as a major public health hazard, exposure to this mineral's fibers was implicated in the development of RA lesions. 13 Asbestos-related RA was usually found coexisting with other types of asbestos-induced pleuropulmonary disease, and only occasionally solitary. Still today, asbestos exposure is considered to be the leading etiologic factor, accounting for 29-86% of the cases of RA in various series. 7, 14 Not only occupational, but also environmental asbestos exposure has been associated with RA. One pioneer report traced an unexpectedly high number of RA patients without occupational asbestos exposure to Metsovo, Greece, an area with documented environmental exposure to tremolite (''Metsovo lung''). 15 Inhalation of mineral dusts other than asbestos, such as silica (silicosis-associated RA), and mixed mineral dusts (mixed dust pneumoconiosis-associated RA), have also been reported to cause RA. 16, 17 However, it has been recently shown that pleural effusions can lead to RA development in the absence of asbestos or other mineral dust exposure. 18 RA more commonly develops during the healing course of a pleural effusion, rather than during the active disease process. Exudative/ inflammatory effusions that cause pleural thickening exhibit a greater propensity for RA generation than transudative ones. 11, 19 Pleurisy is the second leading cause of RA, accounting for approximately 14-64% of cases.
14 RA has been observed with virtually all types of pleural effusions. This fact indicates its close association with the process of pleural inflammation, and not the specific causative agent that triggers it. RA has been reported with acute parapneumonic, chronic empyematous and tuberculous effusions, post-traumatic hemothoraces, effusions after coronary artery surgery, and effusions occuring in chronic hemodialysis patients. 14, [20] [21] [22] In many cases pleural involvement is clinically silent, and pulmonary parenchymal disease dominates early clinical manifestations. In these cases RA appears insidiously as a chronic sequella of clinically silent pleurisy. In this setting, RA has been reported with Legionella pneumophila pneumonia, histoplasmosis, and end-stage chronic renal disease. [23] [24] [25] Finally, RA has been vaguely associated with primary spontaneous pneumothorax and secondary spontaneous pneumothorax due to neurilemmomatosis. It has been reported in children with cancer, and in a healthy young person with no past medical history. 8, 26 A differential diagnostic list of probable causes of RA is given in Table 1 . 14 Asbestos-related RA tends to give symptoms more often than nonasbestos-related RA. Even then, it is not clear if symptoms are caused by the underlying disease rather than by RA. Physical findings are minimal to absent; the presence of a few scattered deepinspiratory crackles, accompanied by scarce friction rub heard over the affected area is the exception in our experience. The prevalence of smoking among RA patients has been reported to be much higher than in the general population. This fact may have significant implications in the pathogenesis of RA lesions. RA is usually encountered in two clinical settings: either as an incidental finding in an otherwise healthy person with or without a pleural history, or during long-term follow-up of an asbestos exposed worker. The latter situation poses a greater diagnostic challenge, as RA has to be confidently discriminated from malignancy in subjects that often have pulmonary co-morbidity and therefore run a greater risk from interventional procedures.
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No laboratory test is sensitive or specific for RA. One study found an elevated erythrocyte sedimentation rate in patients suffering from extensive pleural sequellae due to asbestos exposure, in comparison to subjects suffering only from asbestosis or pleural plaques. 27 Solitary RA causes no significant functional impairment, if it is not accompanied by other pleural or parenchymal sequellae, especially diffuse pleural thickening. 28 Thus, functional impairment is common in patients with asbestos-related RA that often have co-existing diffuse parenchymal or pleural involvement, while lung function studies are usually normal in nonasbestos-related RA patients. Even when functional impairment is present, it is non-specific; obstructive, restrictive, or mixed. 28 Thus, lung function testing serves only for follow-up purposes, and does not provide clues on RA's etiology.
Radiological features
Imaging techniques are the sole laboratory tests that possess satisfactory sensitivity and specificity for RA. Older techniques, such as plain chest radiography and plain tomography can simply outline the lesion, contributing little towards its differential diagnosis from other round intrathoracic opacities. Even this is not always readily accomplished, as an estimated 50% of RAs are not detected by chest X-rays (CXR). However, newer imaging modalities such as CT, high-resolution computed tomography (HRCT), ultrasonography, magnetic resonance imaging (MRI), and positron emission tomography (PET), can accurately capture and delineate specific features of RA. In recent years they have increased its detection frequency, making it appear all the more often in clinical practice. RA is usually solitary and unilateral, but can occasionally be multiple and bilateral. Up to three lesions have been reported in the same patient.
14,29 Non-asbestos-related RA is commonly located in dependent (basal, posterior, and paraspinal) lung regions. It also exhibits a striking propensity for being located in the middle lobe and the lingula. Expectedly, asbestos-related RA is preferentially located in inhalational mainstream targeted areas (lower lobes, lingula, middle lobe). As these two patterns overlap to a large extent, RA's location does not suggest a specific cause.
Plain CXR findings
RA is most often discovered on CXR, where it appears as a round, spindle-, or wedge-shaped opacity with hazy, irregular borders, always measuring less than 7 cm in diameter. It is located peripherally, and is in contact with thickened pleura. Its opacity emulates that of soft tissue, and the angles formed by its borders and the pleura are sharp. There is some degree of volume loss of the ipsilateral lung field, and the ''comet-tail'' sign is occasionally observed. 30 This hallmark of RA is a variation of the ''cranial tilting'' sign originally described by Hanke. He defined it as ''the abrupt cephalad displacement of the linear opacities (pulmonary vessels) immediately after exiting the lesion''. 2 Frontal and lateral classic tomography is no longer in routine use, and has been replaced by CT. However, it used to hold additional diagnostic value compared to CXR, since it better delineates the ''comet-tail'' sign and the irregularly thickened pleura. 10 In some cases the ''comet-tail'' sign and RA's close proximity to the visceral pleura is not obvious on CXR, and it appears as a SPN. These primary CXR-features of RA are often accompanied by secondary signs, such as diffuse pleural thickening, pleural effusion, pleural plaques, fibrothorax or even a blunted costophrenic angle; these are often helpful by suggesting the underlying cause.
CT findings
With the advent of CT-scanning a new arsenal of signs was developed that often facilitates noninvasive diagnosis of RA. RA appears on CT-scans as a rounded peripheral mass abutting thickened pleura. Its diameter lies between 3.5 and 7 cm and its density is close to that of soft tissue. Enhancement after contrast agent injection is observed, but is very variable. It exhibits speculated margins that form sharp angles with the pleural surface. Interlobar fissures or main stem bronchi may be displaced as there is always some degree of volume loss associated with RA. 31 Calcifications and extraparietal pleural fat accumulation may be found within the thickened neighboring pleura or within the mass itself. 31 RA's hilar margins are spiculated by incoming vessels. 29 Before these vessels enter the lesion, they are strangulated and angled, creating the characteristic appearance of converging bronchovascular markings, alias the ''comet-tail'' sign, which is the diagnostic hallmark of the lesion and can be seen in virtually all cases. 29, 31 Ordinarily, RA exhibits a centrally located air bronchogram. The periphery of the lesion may appear denser than its more radiolucent center. 31 Mediastinal lymph nodes are never enlarged in RA; the finding of hilar or mediastinal lymph node enlargement is suggestive of malignant disease. In silicosis-associated RA, silicotic nodules can be seen inside RA lesions and throughout the lung parenchyma. 16 One study concluded that the most useful CT-criteria for diagnosing asbestos-related RA were: (a) contiguity to areas of diffuse pleural thickening, (b) lentiform or wedge-shaped outline, (c) volume-loss, and (d) the ''comet-tail'' sign. 32 The CT-findings of RA are summarized in Table 2 . Although HRCT is not superior to conventional CT in imaging RA, they have different capabilities of depicting coexisting lesions. HRCT is much more valuable in uncovering diffuse interstitial processes, whereas conventional CT is highly sensitive and specific in delineating pleural plaques. 6 The choice between either technique should rely on the clinical context of RA's presentation and on the findings on plain CXR films.
Ultrasound findings
Ultrasound scans have not improved diagnostic accuracy for RA compared to CT-scans. However, they would be advantageous over CT if they could reach equivalent resolutions for reasons of clinical feasibility and radioprotection. Ultrasound findings of RA include a pleural-based hyper-echogenic area, adjacent pleural thickening with extrapleural fat, and a highly echogenic line extending from the pleura into the ''mass'', which is believed to represent the scarred invaginated visceral pleura. 33 
Magnetic resonance imaging findings
In recent years patients with RA have been studied with MRI, and the MRI-signs of RA have been recognized. The lesion produces a signal that is higher than that of muscle and lower than that of fat on T1-weighted images, while on T2-weighted images the signal is similar to or lower than that of fat. The atelectatic mass enhances homogeneously after gadopentate dimeglumine administration. The abutting thickened pleura produces no signal and can be more clearly identified on T2-weighted images. A characteristic ''kidney-like'' pattern, i.e. 34 Though MRI is capable of depicting the lesion in greater detail, it seems to have little more to offer towards diagnosing RA compared to CT.
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Positron emission tomography (PET) findings
RA has been shown to be metabolically inactive on 2-[18F]-fluoro-2-deoxy-D-glucose (FDG)-PET scans. FDG-PET can therefore help in differential diagnosing RA from malignant lesions when CT is equivocal. 35 This imaging modality is valuable in the discrimination of malignant from non-malignant SPNs (80% sensitivity, 94% specificity). Newer FDG-PET techniques, like dual time-point FDG-PET hold promise for even greater diagnostic accuracy (100% sensitivity, 89% specificity). 36 Limited spatial resolution is overcome by CT-PET co-registration images. A major limitation for widespread use of FDG-PET as a first-line imaging modality for SPNs and RA is its still limited availability and costeffectiveness.
Illustrative case
A 30-year-old male non-smoking patient was subjected to serial follow-up with annual CXRs in 1998. He had just successfully completed an anti-tuberculous drug regimen for smear-positive reactivation pulmonary tuberculosis accompanied by tuberculous pleural effusion on the right (6-month/4-drug regimen, consisting of isoniazide 300 mg o.d. plus rifampin 600 mg o.d. for 6 months, with ethambutol 1200 mg o.d. and pyrazinamide 1500 mg o.d. for the first 2.5 months). The pathogenic Mycobacterium tuberculosis strain had tested completely drugsensitive. He had no occupational history of asbestos exposure, nor did he live in an area with documented environmental asbestos pollution. His CXR was completely normal at the initiation of follow-up. After 3 years of uneventful follow-up and while remaining asymptomatic, the patient had an abnormal chest radiograph (Fig. 1 ). An illdefined opacity was discovered in the right lower lung field, accompanied by signs of right lower lobe volume loss (converging bronchovascular markings, mild caudad displacement of the ipsilateral hilum and absence of visibility of the interlobar artery), prompting immediate CT-evaluation. Typical CTscan findings suggested RA (Fig. 2) . No further diagnostic evaluation was deemed necessary, and the patient was re-enrolled in yearly follow-up Figure 1 RA in a 30-year old male with a history of pleuropulmonary tuberculosis, at the 3 years' follow-up session. Posteroanterior chest radiograph demonstrating an ill-defined opacity in the posterior-medial aspect of the right lower lobe, which is accompanied by converging bronchovascular markings. There is also a mild caudad displacement of the ipsilateral hila and absence of visibility of the interlobar artery (both are signs of right lower lobe volume loss).
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evaluation. The lesion has been stable and the patient has not had symptoms since.
Clinical course-management
RA is clinically benign. Complications, such as bronchial obstruction, post-obstructive pneumonia, and arterial thrombosis have been reported only once in the same patient. 37 However, when RA is comprised in the spectrum of asbestos-induced lung disease, it constitutes a rather ominous prognostic sign. One study found asbestos-induced pleural changes (such as RA) to be (a) overtly progressive, (b) profound effectors of overall lung function independently of the presence of parenchymal changes, and (c) hallmarks of ensuing parenchymal involvement. 38 The co-existence of pleural effusions has also been found to be a dismal prognostic marker for the development of CXR abnormalities and lung function impairment. 39 Thus, RA usually follows a clinically silent and indolent course, but the diseases processes that cause it may not do so.
The diagnosis of RA is based on radiologic criteria with sufficient security. Most authorities agree that CT is an almost perfect tool for the confident diagnosis of RA, accurate enough to obviate exploratory or resectional thoracotomy most of the times. However, only one study has addressed this matter systematically. 40 The authors of this study found adjacent pleural thickening and pleural-based location to be the most sensitive markers for RA (100% each), but lacking specificity (33% and 67%, respectively). They also found the sign of converging bronchovascular markings (''comet-tail sign'') to be most reliable (sensitivity 83%, specificity 92%) and concluded that although the diagnostic accuracy of CT for RA was high it was nevertheless imperfect. They stated that no single CT-criterion alone, but rather a combination thereof, is sufficient to securely exclude alternative diagnoses. Additional imaging modalities, such as MRI, FDG-PET or ultrasonography, can help as adjuvant diagnostic tools in equivocal cases.
Fine needle aspiration or percutaneus CT-guided biopsy are not indicated for the vast majority of patients with typical RA. They probably have a role in ambiguous cases, where radiologic criteria cannot establish a firm diagnosis and rule out malignancy. When implemented, it is important to remember that only positive results are valuable; the negative predictive value of these tests for cancer is low due to limited sampling. In equivocal cases of atypical, ill-defined masses in patients at high risk for having cancer, the surgical procedure of choice is video-assisted thoracoscopic surgery. This procedure is associated with less morbidity and mortality than open thoracotomy, and provides satisfactory diagnostic accuracy. 41 It should be implemented before the final decision on open lung biopsy. Video-assisted thoracoscopic surgery nevertheless pre-requisites adequate lung function because it is performed under general anesthesia and selective main-stem bronchi pertubation. Medical thoracoscopy, a recently emerged technique that is even less invasive than video-assisted thoracoscopic surgery, should be better suited for patients who are borderline or inadequate in terms of respiratory and/or cardiac reserve. 42 These minimally invasive procedures gain an even greater role in the management of unoperable or border- Figure 2 The same patient as in Fig. 1. (A) CT (soft tissue window): a mass of soft tissue density is seen in the right lower lobe paraspinally (white arrow) abutting a thickened pleura (thin black arrows). The bold black arrow points to a focus of calcification in the thickened pleura. (B) HRCT: the ''comet-tail'' sign confirms the presumable diagnosis (arrows).
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line patients. They are invaluable in high-risk cases, to which every possible exclusion criterion for resectional surgery has to be applied. Exploratory surgery is frequently offered to RA patients as the final diagnostic option; the leading cause for this is the fear of malignancy. 43 However, it is important to remember that pathological confirmation of the radiological diagnosis of RA is not necessary in most instances.
The main differential diagnosis to RA is malignancy originating in or metastasizing to the lung or pleura, keeping in mind the rare case of coexistence of both. This is the reason for the categorization of RA under the heading of ''lung pseudotumors''. Other diseases that produce a similar radiologic picture are round pneumonia, round focuses of radiation pneumonitis, plasma cell granuloma, Wegener's granulomatosis, neurogenic tumors, lung abscess, mycobacterial, fungal and lymphoproliferative diseases, etc.
There is no specific treatment for RA. Surgical intervention should be considered only if RA's impact on lung function is profound, or when serious fear of coexisting malignancy is substantiated. 44, 45 Discussion RA can be found acutely at the time of discovery of a pleural effusion, subacutely during decrease of a pleural effusion or chronically long after a pleural effusion or asbestos exposure. 18, 20 The main histopathological lesion is a focus of local visceral pleural fibrosis, underneath which lies a wrinkled and folded pleura. The latter sometimes projects deep invaginations into the underlying pulmonary parenchyma. Not a discrete mass, but a compressed lung region showing focuses of interstitial fibrosis corresponds to the radiopacity. 11 RA has been found to be a purely visceral pleural lesion, in contrast to pleural plaques, which are of parietal pleural origin.
The mechanism of RA formation is still under debate. Two main theories have emerged attempting to explain its development: the ''folding (pleural effusion)'' and the ''fibrosing (pleural injury)'' concepts. 11, 12 The ''folding (pleural effusion)'' theory suggests that the initial event in the pathogenesis of RA is lung parenchymal compression and subsequent invagination by loculized accumulation of pleural fluid. The ''fibrosing (pleural injury)'' theory suggests the initial event for RA's formation to be local visceral pleural inflammation. This leads to repair, which in turn leads to fibrosis. The subsequent contraction of this visceral pleural fibrotic focus leads to RA of the underlying lung parenchyma (Figs. 3A and B) . To date both theories stand in a complementary fashion. We propose microbronchial distortion as an additional mechanism for RA formation (Fig.  3C) . Strangulation of small airways with subsequent peripheral gas absorption and focal atelectasis could explain the preferential location of RA in the middle lobe and the lingula and its epidemiological association with smoking. In contrast to the pleural thickening and parenchymal fibrosis concepts, this mechanism could also explain the observed late regression of chronically persistent lesions.
The relationship of RA to malignancy comprises two important issues. The first one is its close resemblance to malignant lung and mesothelial tumors, and the task of differential diagnosis thereby set before the clinician and the radiologist. The second issue is whether asbestos-related RA by itself pre-disposes to malignancy or not. Only one study has adressed the latter. The authors of this study tried to correlate radiologic lesions with mineralogic data in asbestos exposed individuals. 46 They found statistically significant higher tissue retention of asbestos bodies in patients with RA and coexisting diffuse pleural thickening and/or interstitial fibrosis, in comparison to patients with isolated pleural plaques. They concluded that the The ''fibrosing (pleural injury) theory'': contraction of a focus of visceral pleural fibrosis (vertical arrows) causes shrinkage of underlying parenchyma (curved and horizontal arrows). (C) Proposed ''microbronchial distortion'': increasing pleural fluid pressure (black arrow), and/or visceral pleural fibrotic plaque contraction (long white arrow), cause displacement of underlying pulmonary parenchyma (short white arrow), and distortion of small bronchi (black arrowhead) with subsequent peripheral gas absorption.
former should be considered at a higher risk for lung cancer. On the contrary, the presence of excessive risk for lung cancer in patients with RA and pleural plaques only was more questionable, as they were found to have asbestos body tissue retentions either above or below those associated with pleural plaques alone. Based on these data one can conclude, that RA is not a pre-neoplastic lesion per se, but that specific coexisting asbestosinduced lesions in exposed individuals, in fact are. Nevertheless, what asbestos-induced RA is concerned; it is a sign of exposure to a known carcinogen. Upon discovery of such a lesion, patients should by all means be subjected to close follow-up.
Conclusion
Our knowledge about the entity called RA has grown substantially in recent years. A great proportion of this understanding has been aquired in a non-systematic manner, probably due to the small number of patients presenting with this disorder. As the use of modern imaging modalities results in increased detection frequency of RA, a more uniform clinical management should be implemented. RA is a part of the wide spectrum of sequellae resulting from insults to the visceral pleura by pathogenic processes. It is characterized by great discrepancy between minimal clinical and impressive radiologic findings. Awareness of this uncommon entity is important if it is to be diagnosed accurately.
